LECZENIE RAN 2024; 21 (4)
Chronic wounds represent a significant health issue affecting a broad spectrum of patients, particularly in the fields of gynecology and obstetrics. In these specialties,chronic wounds encompass a wide range of…
Chronic wounds represent a significant health issue affecting a broad spectrum of patients, particularly in the fields of gynecology and obstetrics. In these specialties,chronic wounds encompass a wide range of…
Wound treatment remains a significant challenge in modern medicine. Initiatives undertaken by the medical community, including the Wound Healing Society’s activities and specialist publications, attempt to optimise standards of care for patients with wounds. The current epidemiological situation in this patient group requires urgent systemic intervention.
Chronic wound care has improved tremendously through the years due to technological advancements and medical innovations. However, wound care does not only mean the application of a wound dresssing merely. The wound should be evaluated aetiologically, and care should be planned according to the disruption in which stage of the healing has occurred [1]. The patient must be evaluated as a whole, and all systemic disturbances should be determined such as blood sugar irregularity in a diabetic foot patient and venous hypertension in a venous ulcer patient.
Patients with diabetes and a foot ulcer are best cared for at a multidisciplinary specialist clinic to enable as many as possible to heal without amputation. However, it is all too common that many patients return with a new ulcer within a year or two on the same or on the contralateral foot [1, 2]. To support these patients trying to reduce new ulceration, some measures are recommended
Wound management is a huge field which is expanding exponentially and there are many stakeholders from different specialties involving multidisciplinary teams dedicated to healing hard to heal wounds with minimal or no complications with the proper standard of care. Many new modalities such as biotherapy, adjunct therapies, new advanced dressing, solutions and others are frequently introduced globally.
Diabetic foot ulcers (DFUs) remain a major complication of diabetes, affecting approximately 18.6 million people worldwide each year. As outlined in the comprehensive JAMA review by Tze Woei Tan, Andrew Boulton, Sicco Bus and myself, DFUs lead to high rates of hospitalization, amputation, and death. Several recent advances provide hope for improved prevention and treatment of these debilitating wounds. Epidemiological studies have further delineated the disproportionate burden of DFUs and amputations among minorities and those of lower socioeconomic status. For example, long-term rates of major amputation were nearly 3-fold higher in Black vs. White Medicare beneficiaries in the United States. Efforts to address such disparities must remain a priority globally.
The incredible development of artificial intelligence (AI) observed in recent times has caused increasingly individual medical disciplines, and medical fields are trying to find in this interesting tool an application for themselves.